BWX Limited’s share prices declined after BMX decided to remain Independent

BWX Limited’s (ASX: BWX) share prices declined 1.343 percent on 17 September 2018 after BMX strategic review concludes that BMX is going to remain as Independent. As per the release, Independent Board Committee (IBC) had agreed to continue in discussions with Bain Consortium to determine whether a binding proposal which is in the best interest of BWX shareholders could be developed or not. After the conclusion of those discussions, now the Company has announced that the Bain Consortium has not been able to submit a binding proposal and hence withdrawn its indicative proposal.

During the Strategic review, many parties have approached BWX with the Joint venture, licensing and distribution proposals which are having a potential of increasing the growth of BWX’s brands in international markets. Hence BWX has decided that it will continue exploring these opportunities. This process of exploring the potential for a change of control proposal has given an opportunity for the company to validate the existing strategies and identify new growth opportunities. The company will now be focusing on the expansion of market share of all key BWX brands in existing markets and diversifying into new geographies and channels. The company will also try to enhance its e-commerce presence by capitalizing on nourished Life’s digital capabilities. Also, the company will try to accelerate the growth of the Sukin brand domestically and globally.

Interim CEO Myles Anceschi has been appointed as permanent CEO of the Company. He will join BWX Board of Directors as the Managing Director. Also, Mr. John Humble who has served as Managing director and Chief executive Officer and Mr. Aaron Finlay who has served financial Director and joint Company Secretary, both have agreed to resign from their executive and board roles.

During the FY 2018, the company has earned a Revenue of $148.7m which is 105% more than compared to last year revenue. The underlying EBITDA is $40.3 million which is 52% higher than the previous year. The Underlying NPAT was $40.3 million this year. 

BWX’s shares were traded at $4.00 at a market capitalization of $507.43 million as of 17 September 2018 (AEST 04:00 P.M.).

Dividend Stocks To Buy

Sponsored ad by Kalkine

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Facebook Comments

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report

LEAVE A REPLY

Please enter your comment!
Please enter your name here